|
16.2.2012 |
LV |
Eiropas Savienības Oficiālais Vēstnesis |
C 44/6 |
Zāles – Tirdzniecības atļaujas, kas piešķirtas EEZ EBTA valstīs 2011. gada pirmajā pusgadā
2012/C 44/05
I apakškomiteja preču brīvas aprites jautājumos
Jāpaziņo EEZ Apvienotajai komitejai
Atsaucoties uz EEZ Apvienotās komitejas 1999. gada 28. maija Lēmumu Nr. 74/1999, EEZ Apvienotā komiteja tiek aicināta 2011. gada 30. septembra sanāksmē paziņot šādus sarakstus attiecībā uz zāļu tirdzniecības atļaujām, kas piešķirtas laikposmā no 2011. gada 1. janvāra līdz 30. jūnijam:
|
I pielikums |
Jaunu tirdzniecības atļauju saraksts |
|
II pielikums |
Atjaunotu tirdzniecības atļauju saraksts |
|
III pielikums |
Pagarinātu tirdzniecības atļauju saraksts |
|
IV pielikums |
Atsauktu tirdzniecības atļauju saraksts |
|
V pielikums |
Apturētu tirdzniecības atļauju saraksts |
I PIELIKUMS
Jaunu tirdzniecības atļauju saraksts
Šādas tirdzniecības atļaujas piešķirtas EEZ EBTA valstīs laika posmā no 2011. gada 1. janvāra līdz 30. jūnijam:
|
ES numurs |
Ražojums |
Valsts |
Atļaujas piešķiršanas datums |
|
EU/1/09/578/001 |
Pandēmijas gripas vakcīna (H5N1) (šķelts, inaktivēts virions, pievienots adjuvants) GlaxoSmithKline Biologicals |
Islande |
29.4.2011. |
|
EU/1/10/635/001-014 |
Olanzapin Apotex |
Norvēģija |
14.2.2011. |
|
EU/1/10/639/001-030 |
Telmisartan Actavis |
Norvēģija |
17.3.2011. |
|
EU/1/10/641/001 |
Ruconest |
Islande |
24.1.2011. |
|
EU/1/10/642/001-004 |
Ibandronic Acid Teva |
Islande |
17.1.2011. |
|
EU/1/10/647/001-002 |
Myclausen |
Islande |
21.1.2011. |
|
EU/1/10/647/001-028 |
Twynsta |
Islande |
21.1.2011. |
|
EU/1/10/650/001-015 |
Clopidogrel Teva Generics B.V. |
Islande |
1.2.2011. |
|
EU/1/10/651/001-015 |
Clopidogrel HCS |
Islande |
1.2.2011. |
|
EU/1/10/654/001-004 |
Leflunomide ratiopharm |
Islande |
14.3.2011. |
|
EU/1/10/656/001-006 |
Possia |
Islande |
13.1.2011. |
|
EU/1/10/656/001-006 |
Possia |
Norvēģija |
25.1.2011. |
|
EU/1/10/657/001-002 |
Pirmspandēmijas gripas vakcīna (H5N1) (virsmas antigēni, inaktivēti, pievienots adjuvants) Novartis Vaccines and Dia |
Islande |
14.3.2011. |
|
EU/1/10/657/001-002 |
Pirmspandēmijas gripas vakcīna |
Norvēģija |
3.1.2011. |
|
EU/1/10/658/001-002 |
Aflunov |
Islande |
14.3.2011. |
|
EU/1/10/658/001-002 |
Aflunov |
Norvēģija |
3.1.2011. |
|
EU/1/10/659/001-010 |
Iasibon |
Islande |
14.2.2011. |
|
EU/1/10/659/001-010 |
Iasibon |
Norvēģija |
17.2.2011. |
|
EU/1/10/659/001-010 |
Iasibon |
Lihtenšteina |
28.2.2011. |
|
EU/1/10/660/001-002 |
Potactasol |
Islande |
16.3.2011. |
|
EU/1/10/660/001-002 |
Potactasol |
Lihtenšteina |
28.2.2011. |
|
EU/1/10/661/001-002 |
Fluenz |
Islande |
16.3.2011. |
|
EU/1/10/661/001-002 |
Fluenz |
Lihtenšteina |
28.2.2011. |
|
EU/1/10/662/001-002 |
Docetaxel Teva Pharma |
Islande |
17.2.2011. |
|
EU/1/10/662/001-002 |
Docetaxel Teva Pharma |
Lihtenšteina |
28.2.2011. |
|
EU/1/10/662/001-002 |
Docetaxel Teva Pharma |
Norvēģija |
17.3.2011. |
|
EU/1/10/662/001-002 |
Docetaxel Teva Pharma |
Norvēģija |
17.3.2011. |
|
EU/1/10/663/001-002 |
Lamivudine/Zidovudine Teva |
Norvēģija |
31.3.2011. |
|
EU/1/10/663/001-002 |
Lamivudine/Zidovudine Teva |
Lihtenšteina |
30.4.2011. |
|
EU/1/10/664/001 |
Pumarix |
Islande |
8.4.2011. |
|
EU/1/10/664/001 |
Pumarix |
Norvēģija |
13.4.2011. |
|
EU/1/10/664/001 |
Pumarix |
Lihtenšteina |
30.4.2011. |
|
EU/1/10/665/001-004 |
Entacapone Teva |
Islande |
21.3.2011. |
|
EU/1/10/665/001-004 |
Entacapone Teva |
Norvēģija |
4.4.2011. |
|
EU/1/10/665/001-004 |
Entacapone Teva |
Lihtenšteina |
30.4.2011. |
|
EU/1/11/666/001-003 |
Libertek |
Islande |
24.3.2011. |
|
EU/1/11/666/001-003 |
Libertek |
Norvēģija |
15.3.2011. |
|
EU/1/11/666/001-003 |
Libertek |
Lihtenšteina |
30.4.2011. |
|
EU/1/11/667/001-003 |
Esbriet |
Lihtenšteina |
30.4.2011. |
|
EU/1/11/667/001-003 |
Esbriet |
Islande |
25.3.2011. |
|
EU/1/11/667/001-003 |
Esbriet |
Norvēģija |
15.3.2011. |
|
EU/1/11/667/001-003 |
Esbriet |
Norvēģija |
15.3.2011. |
|
EU/1/11/668/001-003 |
Daliresp |
Islande |
12.4.2011. |
|
EU/1/11/668/001-003 |
Daliresp |
Norvēģija |
15.3.2011. |
|
EU/1/11/668/001-003 |
Daliresp |
Lihtenšteina |
30.4.2011. |
|
EU/1/11/669/001-004 |
Teysuno |
Islande |
12.4.2011. |
|
EU/1/11/669/001-004 |
Teysuno |
Norvēģija |
24.5.2011. |
|
EU/1/11/669/001-004 |
Teysuno |
Lihtenšteina |
30.4.2011. |
|
EU/1/11/671/001 |
Xiapex |
Islande |
28.3.2011. |
|
EU/1/11/671/001 |
Xiapex |
Norvēģija |
31.3.2011. |
|
EU/1/11/671/001 |
Xiapex |
Lihtenšteina |
30.4.2011. |
|
EU/1/11/672/001-006 |
Xeplion |
Islande |
8.4.2011. |
|
EU/1/11/672/001-006 |
Xeplion |
Norvēģija |
5.4.2011. |
|
EU/1/11/672/001-006 |
Xeplion |
Lihtenšteina |
30.4.2011. |
|
EU/1/11/673/001-024 |
Ifirmacombi |
Islande |
4.4.2011. |
|
EU/1/11/673/001-024 |
Ifirmacombi |
Norvēģija |
6.4.2011. |
|
EU/1/11/673/001-024 |
Ifirmacombi |
Lihtenšteina |
30.4.2011. |
|
EU/1/11/674/001-010 |
Repso |
Islande |
13.4.2011. |
|
EU/1/11/674/001-010 |
Repso |
Norvēģija |
26.4.2011. |
|
EU/1/11/674/001-010 |
Repso |
Lihtenšteina |
30.4.2011. |
|
EU/1/11/675/001-0010 |
Leflunomide Teva |
Islande |
8.4.2011. |
|
EU/1/11/675/001-010 |
Lefluomide Teva |
Norvēģija |
11.4.2011. |
|
EU/1/11/675/001-010 |
Leflunomid Teva |
Lihtenšteina |
30.4.2011. |
|
EU/1/11/676/001 |
Jevtana |
Islande |
12.4.2011. |
|
EU/1/11/676/001 |
Jevtana |
Norvēģija |
6.4.2011. |
|
EU/1/11/676/001 |
Jevtana |
Lihtenšteina |
30.4.2011. |
|
EU/1/11/677/001-004 |
Gilenya |
Islande |
13.4.2011. |
|
EU/1/11/677/001-004 |
Gilenya |
Norvēģija |
28.3.2011. |
|
EU/1/11/677/001-004 |
Gilenya |
Lihtenšteina |
30.4.2011. |
|
EU/1/11/678/001-002 |
Halaven |
Islande |
14.4.2011. |
|
EU/1/11/678/001-002 |
Halaven |
Norvēģija |
6.4.2011. |
|
EU/1/11/678/001-002 |
Halaven |
Lihtenšteina |
30.4.2011. |
|
EU/1/11/679/001-006 |
Pravafenix |
Islande |
10.5.2011. |
|
EU/1/11/679/001-006 |
Pravafenix |
Norvēģija |
11.5.2011. |
|
EU/1/11/679/001-006 |
Pravafenix |
Lihtenšteina |
30.4.2011. |
|
EU/1/11/680/001-080 |
Riprazo HCT |
Islande |
29.4.2011. |
|
EU/1/11/680/001-080 |
Riprazo HCT |
Norvēģija |
24.5.2011. |
|
EU/1/11/680/001-080 |
Riprazo HCT |
Lihtenšteina |
30.4.2011. |
|
EU/1/11/681/001-013 |
Trobalt |
Islande |
19.4.2011. |
|
EU/1/11/681/001-013 |
Trobalt |
Norvēģija |
4.4.2011. |
|
EU/1/11/681/001-013 |
Trobalt |
Lihtenšteina |
30.6.2011. |
|
EU/1/11/681/001-013 |
Trobalt |
Lihtenšteina |
30.4.2011. |
|
EU/1/11/682/001 |
Methylthioninium chloride Proveblue |
Islande |
6.6.2011. |
|
EU/1/11/682/001 |
Methylhionininium chloride Proveblue |
Norvēģija |
27.6.2011. |
|
EU/1/11/682/001 |
Methylthioninchlorid Proveblue |
Lihtenšteina |
30.6.2011. |
|
EU/1/11/686/001-056 |
Rasilamlo |
Islande |
12.5.2011. |
|
EU/1/11/686/001-056 |
Rasilamlo |
Norvēģija |
24.5.2011. |
|
EU/1/11/686/001-056 |
Rasilamlo |
Lihtenšteina |
30.4.2011. |
|
EU/1/11/687/001-012 |
Hizentra |
Islande |
12.5.2011. |
|
EU/1/11/687/001-012 |
Hizentra |
Norvēģija |
9.5.2011. |
|
EU/1/11/687/001-012 |
Hizentra |
Lihtenšteina |
30.4.2011. |
|
EU/1/11/688/001 |
Cinryze |
Islande |
28.6.2011. |
|
EU/1/11/688/001 |
Cinryze |
Norvēģija |
27.6.2011. |
|
EU/1/11/691/001-005 |
Eliquis |
Norvēģija |
31.5.2011. |
|
EU/1/11/691/001-005 |
Eliquis |
Lihtenšteina |
30.6.2011. |
|
EU/1/11/692/001 |
Yellox |
Islande |
28.6.2011. |
|
EU/1/11/692/001 |
Yellox |
Norvēģija |
10.6.2011. |
|
EU/1/11/692/001 |
Yellox |
Lihtenšteina |
30.6.2011. |
|
EU/1/11/693/001-016 |
Rivastigmine Actavis |
Islande |
28.6.2011. |
|
EU/1/11/693/001-016 |
Rivastigmine Actavis |
Lihtenšteina |
30.6.2011. |
|
EU/1/190/649/001-016 |
Clopidogrel Teva Pharma B.V. |
Islande |
30.6.2011. |
|
EU/1/98/058/001-002 |
Lamivudine/Zidovudine Teva |
Islande |
12.4.2011. |
|
EU/1/98/058/001-002 |
Lamivudine |
Norvēģija |
31.3.2011. |
|
EU/2/11/120/001-003 |
Zulvac 1 + 8 Ovis |
Lihtenšteina |
30.4.2011. |
|
EU/2/11/126/001 |
MS-H Impfstoff |
Lihtenšteina |
30.6.2011. |
|
EU/2/10/107/001-014 |
Veraflox |
Islande |
10.5.2011. |
|
EU/2/10/107/001-014 |
Veraflox |
Norvēģija |
24.6.2011. |
|
EU/2/10/107/001-014 |
Veraflox |
Lihtenšteina |
30.4.2011. |
|
EU/2/10/109/001-009 |
RHINISENG |
Norvēģija |
3.1.2011. |
|
EU/2/10/110/001-002 |
Coxevac |
Islande |
26.1.2011. |
|
EU/2/10/111/001-004 |
Meloxoral |
Islande |
14.3.2011. |
|
EU/2/10/111/001-004 |
Meloxoral |
Norvēģija |
3.1.2011. |
|
EU/2/10/112/001-005 |
BTVPUR ALSap 1 |
Islande |
10.2.2011. |
|
EU/2/10/112/001-005 |
BTVPUR ALSap 1 |
Lihtenšteina |
28.2.2011. |
|
EU/2/10/113/001-005 |
BTVPUR ALSap 1-8 |
Islande |
10.2.2011. |
|
EU/2/10/113/001-005 |
BTVPUR ALSap 1-8 |
Lihtenšteina |
28.2.2011. |
|
EU/2/10/114/001-002 |
Hiprabovis IBR Marker Live |
Islande |
16.3.2011. |
|
EU/2/10/114/001-002 |
Hiprabovis IBR Marker Live |
Norvēģija |
9.2.2011. |
|
EU/2/10/114/001-002 |
Hiprabovis IBR Marker Live |
Lihtenšteina |
28.2.2011. |
|
EU/2/10/115/001-010 |
Comfortis |
Islande |
22.3.2011. |
|
EU/2/10/115/001-010 |
Comfortis |
Norvēģija |
22.2.2011. |
|
EU/2/10/115/001-010 |
Comfortis |
Lihtenšteina |
30.4.2011. |
|
EU/2/10/115/001-010 |
Comfortis |
Norvēģija |
22.2.2011. |
|
EU/2/10/116/001-004 |
Melosus |
Islande |
24.3.2011. |
|
EU/2/10/116/001-004 |
Melosus |
Norvēģija |
14.4.2011. |
|
EU/2/10/116/001-004 |
Melosus |
Lihtenšteina |
30.4.2011. |
|
EU/2/10/117/001-002 |
Purevax Rabies |
Islande |
21.3.2011. |
|
EU/2/10/117/001-002 |
Purevax Rabies |
Norvēģija |
4.4.2011. |
|
EU/2/10/117/001-002 |
Purevax Rabies |
Lihtenšteina |
30.4.2011. |
|
EU/2/10/118/001-014 |
Activyl |
Islande |
21.3.2011. |
|
EU/2/10/118/001-014 |
Activyl |
Norvēģija |
1.4.2011. |
|
EU/2/10/118/001-014 |
Activyl |
Lihtenšteina |
30.4.2011. |
|
EU/2/10/119/001-012 |
Cimalgex |
Islande |
21.3.2011. |
|
EU/2/10/119/001-012 |
Cimalgex |
Norvēģija |
1.4.2011. |
|
EU/2/108/001-005 |
BTVPUR ALSap 2-4 0.72 U.SN |
Islande |
10.2.2011. |
|
EU/2/11/120/001-003 |
Zulvac 1 + 8 Ovis |
Islande |
13.4.2011. |
|
EU/2/11/120/001-003 |
Zulvac 1 + 8 Ovis |
Norvēģija |
18.4.2011. |
|
EU/2/11/121/001-009 |
CaniLeish |
Islande |
13.4.2011. |
|
EU/2/11/121/001-009 |
CaniLeish |
Norvēģija |
11.4.2011. |
|
EU/2/11/121/001-009 |
CaniLeish |
Lihtenšteina |
30.4.2011. |
|
EU/2/11/123/001-002 |
Procox |
Islande |
28.6.2011. |
|
EU/2/11/123/001-002 |
Procox |
Norvēģija |
20.6.2011. |
|
EU/2/11/123/001-002 |
Procox |
Lihtenšteina |
30.6.2011. |
|
EU/2/11/124/001-008 |
Zuprevo |
Islande |
6.6.2011. |
|
EU/2/11/124/001-008 |
Zuprevo |
Lihtenšteina |
30.6.2011. |
|
EU/2/11/125/001-008 |
Certifect |
Islande |
6.6.2011. |
|
EU/2/11/125/001-008 |
Certificet |
Lihtenšteina |
30.6.2011. |
|
EU/2/11/126/001 |
MS-H-vaccine |
Islande |
28.6.2011. |
II PIELIKUMS
Atjaunotu tirdzniecības atļauju saraksts
Šādas tirdzniecības atļaujas atjaunotas EEZ EBTA valstīs laika posmā no 2011. gada 1. janvāra līdz 30. jūnijam:
|
ES numurs |
Ražojums |
Valsts |
Atļaujas atjaunošanas datums |
|
EU/1/00/135/001-002 |
DaTSCAN |
Islande |
14.3.2011. |
|
EU/1/00/149/001 |
Panretin |
Islande |
18.1.2011. |
|
EU/1/00/156/002-004 |
Trizivir |
Islande |
14.2.2011. |
|
EU/1/00/166/001-003 |
NeuroBloc |
Islande |
15.2.2011. |
|
EU/1/00/166/001-003 |
NeuroBloc |
Norvēģija |
15.2.2011. |
|
EU/1/00/167/001-008 |
Prevenar |
Islande |
25.3.2011. |
|
EU/1/00/167/001-008 |
Prevenar |
Norvēģija |
3.3.2011. |
|
EU/1/00/167/001-008 |
Prevenar |
Lihtenšteina |
28.2.2011. |
|
EU/1/00/173/001-003 |
Vaniqa |
Islande |
15.4.2011. |
|
EU/1/01/171/001, 007-010, 013-014 |
Rapamune |
Islande |
21.2.2011. |
|
EU/1/01/171/001, EU/1/01/171/007-010 EU/1/01/171/013-014 |
Rapamune |
Norvēģija |
2.2.2011. |
|
EU/1/01/172/001-008 |
Kaletra |
Islande |
21.3.2011. |
|
EU/1/01/172/001-008 |
Kaletra |
Norvēģija |
27.4.2011. |
|
EU/1/01/172/001-008 |
Kaletra |
Lihtenšteina |
30.4.2011. |
|
EU/1/01/173/001-003 |
Vaniqa |
Norvēģija |
3.5.2011. |
|
EU/1/01/173/001-003 |
Vaniqa |
Lihtenšteina |
30.4.2011. |
|
EU/1/01/179/001 |
Osigraft |
Islande |
17.5.2011. |
|
EU/1/01/179/001 |
Osigraft |
Norvēģija |
15.6.2011. |
|
EU/1/01/179/001 |
Osigraft |
Lihtenšteina |
30.6.2011. |
|
EU/1/01/183/001&004-005, 007-008, 011, 013, 015, 018-032 |
HBVAXPRO |
Islande |
18.4.2011. |
|
EU/1/01/183/001, EU/1/01/183/004-005 EU/1/01/183/007-008, EU/1/01/183/011 EU/1/01/183/013, EU/1/01/183/015 EU/1/01/183/018-032 |
HBVAXPRO |
Norvēģija |
14.4.2011. |
|
EU/1/01/187/001 |
DepoCyte |
Islande |
23.6.2011. |
|
EU/1/01/187/001 |
DepoCyte |
Lihtenšteina |
30.6.2011. |
|
EU/1/01/191/001-005 |
Ketek 400 mg |
Islande |
9.6.2011. |
|
EU/1/01/191/001-005 |
Ketek |
Norvēģija |
31.5.2011. |
|
EU/1/01/191/001-005 |
Ketek |
Lihtenšteina |
30.6.2011. |
|
EU/1/01/193/001-002 |
MabCampath |
Islande |
23.6.2011. |
|
EU/1/01/193/001-002 |
MabCampath |
Norvēģija |
15.6.2011. |
|
EU/1/05/312/001 |
Xyrem |
Islande |
14.1.2011. |
|
EU/1/05/313/001-009 |
Ablavar |
Islande |
28.1.2011. |
|
EU/1/05/314/001 |
Kepivance |
Islande |
17.1.2011. |
|
EU/1/05/315/001-002 |
Aptivus |
Islande |
27.1.2011. |
|
EU/1/05/320/001 |
Noxafil |
Islande |
18.1.2011. |
|
EU/1/05/322/001 |
Yttriga |
Islande |
18.3.2011. |
|
EU/1/05/322/001 |
Yttriga |
Norvēģija |
20.1.2011. |
|
EU/1/05/322/001 |
Yttriga |
Lihtenšteina |
28.2.2011. |
|
EU/1/05/323/001-013 |
ProQuad |
Islande |
15.4.2011. |
|
EU/1/05/323/001-013 |
ProQuad |
Norvēģija |
6.4.2011. |
|
EU/1/05/323/001-013 |
ProQuad |
Lihtenšteina |
30.4.2011. |
|
EU/1/05/324/001-002 |
Naglazyme |
Islande |
23.3.2011. |
|
EU/1/05/324/001-002 |
Naglazyme |
Norvēģija |
7.2.2011. |
|
EU/1/05/324/001-002 |
Naglazyme |
Lihtenšteina |
28.2.2011. |
|
EU/1/05/325/002 |
Macugen |
Islande |
15.2.2011. |
|
EU/1/05/325/002 |
Macugen |
Norvēģija |
1.2.2011. |
|
EU/1/05/325/002 |
Macugen |
Lihtenšteina |
28.2.2011. |
|
EU/1/05/328/001-004 |
Cubicin |
Islande |
14.2.2011. |
|
EU/1/05/328/001-004 |
Cubicin |
Norvēģija |
11.1.2011. |
|
EU/1/05/329/001-006 |
Kiovig |
Islande |
24.2.2011. |
|
EU/1/05/329/001-006 |
Kiovig |
Norvēģija |
2.2.2011. |
|
EU/1/05/329/001-006 |
Kiovig |
Lihtenšteina |
28.2.2011. |
|
EU/1/05/330/001-011 |
Rotarix |
Islande |
22.3.2011. |
|
EU/1/05/330/001-011 |
Rotarix |
Norvēģija |
13.5.2011. |
|
EU/1/05/331/001-055 |
Neupro |
Islande |
15.2.2011. |
|
EU/1/05/331/001-055 |
Neupro |
Norvēģija |
10.1.2011. |
|
EU/1/06/332/001-009 |
Omnitrope |
Islande |
28.6.2011. |
|
EU/1/06/332/001-009 |
Omnitrope |
Norvēģija |
5.4.2011. |
|
EU/1/06/332/001-009 |
Omnitrope |
Lihtenšteina |
30.4.2011. |
|
EU/1/06/333/001-003 |
Myozyme |
Islande |
20.4.2011. |
|
EU/1/06/333/001-003 |
Myozyme |
Norvēģija |
22.3.2011. |
|
EU/1/06/333/001-003 |
Myozyme |
Lihtenšteina |
30.4.2011. |
|
EU/1/06/334/001-005 |
Evoltra |
Islande |
18.4.2011. |
|
EU/1/06/334/001-005 |
Evoltra |
Norvēģija |
25.5.2011. |
|
EU/1/06/334/001-005 |
Evoltra |
Lihtenšteina |
30.4.2011. |
|
EU/1/06/335/001 |
Valtropin |
Islande |
12.5.2011. |
|
EU/1/06/335/001 |
Valtropin |
Norvēģija |
3.6.2011. |
|
EU/1/06/335/001 |
Valtropin |
Lihtenšteina |
30.4.2011. |
|
EU/1/06/336/001 |
Tygacil |
Norvēģija |
31.5.2011. |
|
EU/1/06/336/001 |
Tygacil |
Lihtenšteina |
30.6.2011. |
|
EU/1/06/337/001-013 |
M-M-RVAXPRO |
Islande |
16.5.2011. |
|
EU/1/06/337/001-013 |
M-M-RVAXPRO |
Norvēģija |
31.5.2011. |
|
EU/1/06/337/001-013 |
M-M-RVAXPRO |
Lihtenšteina |
30.6.2011. |
|
EU/1/06/338/001-003 |
DuoTrav |
Islande |
21.1.2011. |
|
EU/1/06/339/001-002 |
Preotact |
Islande |
11.5.2011. |
|
EU/1/06/339/001-002 |
Preotact |
Lihtenšteina |
30.4.2011. |
|
EU/1/06/341/001-013 |
Zostavax |
Islande |
18.4.2011. |
|
EU/1/06/341/001-013 |
Zostavax |
Lihtenšteina |
30.4.2011. |
|
EU/1/06/343/001-007 |
Baraclude |
Islande |
23.6.2011. |
|
EU/1/06/343/001-007 |
Baraclude |
Lihtenšteina |
30.6.2011. |
|
EU/1/06/346/001 |
Tysabri |
Islande |
27.6.2011. |
|
EU/1/06/348/001-002 |
RotaTeq |
Islande |
23.6.2011. |
|
EU/1/06/348/001-002 |
RotaTeq |
Norvēģija |
17.6.2011. |
|
EU/1/06/348/001-002 |
RotaTeq |
Lihtenšteina |
28.2.2011. |
|
EU/1/06/354/001-011 |
Competact |
Islande |
24.6.2011. |
|
EU/1/06/354/001-011 |
Competact |
Norvēģija |
23.6.2011. |
|
EU/1/06/354/001-011 |
Competact |
Lihtenšteina |
30.6.2011. |
|
EU/1/06/360/001-013 |
Champix |
Lihtenšteina |
30.6.2011. |
|
EU/1/06/367/001-012 |
Diacomit |
Islande |
11.2.2011. |
|
EU/1/06/367/001-012 |
Diacomit |
Norvēģija |
15.2.2011. |
|
EU/1/06/367/001-012 |
Diacomit |
Lihtenšteina |
28.2.2011. |
|
EU/1/07/423/001-003 |
Vectibix |
Islande |
15.2.2011. |
|
EU/1/07/423/001-003 |
Vectibix |
Norvēģija |
25.1.2011. |
|
EU/1/07/440/001-003 |
Tyverb |
Norvēģija |
3.6.2011. |
|
EU/1/10/625/001 |
Arzerra |
Islande |
22.2.2011. |
|
EU/1/10/625/001-002 |
Arzerra |
Norvēģija |
17.2.2011. |
|
EU/1/10/625/001-002 |
Arzerra |
Lihtenšteina |
28.2.2011. |
|
EU/1/10/628/001-004 |
Votrient |
Islande |
6.6.2011. |
|
EU/1/183/001, 004-005, 007-008, 011, 013, 015, 018-032 |
HBVAXPRO |
Lihtenšteina |
30.4.2011. |
|
EU/1/96/009/001-008 |
Zerit |
Islande |
16.5.2011. |
|
EU/1/96/009/001-009 |
Zerit |
Norvēģija |
6.5.2011. |
|
EU/1/96/009/001-009 |
Zerit |
Lihtenšteina |
30.4.2011. |
|
EU/2/00/026/001-004 |
Porcilis AR-T DF |
Norvēģija |
3.1.2011. |
|
EU/2/00/026/001-006 |
Porcilis AR-T DF |
Islande |
17.1.2011. |
|
EU/2/04/045/001-007 |
Previcox |
Norvēģija |
18.4.2011. |
|
EU/2/04/048/001-002 |
Purevax RCP FeLV |
Norvēģija |
13.4.2011. |
|
EU/2/04/049/001-002 |
Purevax RCCh |
Norvēģija |
13.4.2011. |
|
EU/2/04/050/001-002 |
Purevax RCPCh |
Norvēģija |
13.4.2011. |
|
EU/2/04/051/001-002 |
Purevax RC |
Norvēģija |
13.4.2011. |
|
EU/2/04/052/001-002 |
Purevax RCP |
Norvēģija |
13.4.2011. |
|
EU/2/06/058/004 |
Flexicam |
Islande |
8.4.2011. |
|
EU/2/06/058/004 |
Flexicam |
Norvēģija |
26.4.2011. |
|
EU/2/06/058/004 |
Flexicam |
Lihtenšteina |
30.4.2011. |
|
EU/2/06/059/001 |
Convenia |
Islande |
27.6.2011. |
III PIELIKUMS
Pagarinātu tirdzniecības atļauju saraksts
Šādas tirdzniecības atļaujas pagarinātas EEZ EBTA valstīs laika posmā no 2011. gada 1. janvāra līdz 30. jūnijam:
|
ES numurs |
Ražojums |
Valsts |
Atļaujas pagarināšanas datums |
|
EU/1/01/185/100-111 |
Aranesp |
Islande |
15.4.2011. |
|
EU/1/01/194/003-004 |
INOmax |
Islande |
15.4.2011. |
|
EU/1/02/227/003 |
Neulasta |
Lihtenšteina |
30.4.2011. |
|
EU/1/06/332/010-012 |
Omnitrope |
Islande |
16.6.2011. |
|
EU/1/06/332/010-012 |
Omnitrope |
Lihtenšteina |
30.6.2011. |
|
EU/1/06/354/010-011 |
Competact |
Lihtenšteina |
28.2.2011. |
|
EU/1/06/354/012 |
Competact |
Lihtenšteina |
30.6.2011. |
|
EU/1/06/370/037-039 |
Exforge |
Lihtenšteina |
28.2.2011. |
|
EU/1/06/371/037-039 |
Dafiro |
Lihtenšteina |
28.2.2011. |
|
EU/1/06/373/037-039 |
Imprida |
Lihtenšteina |
28.2.2011. |
|
EU/1/07/387/014-026 |
Advagraf |
Lihtenšteina |
30.6.2011. |
|
EU/1/07/397/002-004 |
Siklos |
Islande |
25.3.2011. |
|
EU/1/07/397/002-004 |
Siklos |
Norvēģija |
5.4.2011. |
|
EU/1/07/397/002-004 |
Siklos |
Lihtenšteina |
30.4.2011. |
|
EU/1/07/401/012-015 |
Alli |
Islande |
16.2.2011. |
|
EU/1/07/401/012-015 |
Alli |
Norvēģija |
26.1.2011. |
|
EU/1/07/404/006-008 |
Flebogamma DIF |
Islande |
17.2.2011. |
|
EU/1/07/404/006-008 |
Flebogamma DIF |
Norvēģija |
14.1.2011. |
|
EU/1/07/404/006-008 |
Flebogamma DIF |
Lihtenšteina |
28.2.2011. |
|
EU/1/07/407/021-040 |
Sprimeo |
Lihtenšteina |
30.4.2011. |
|
EU/1/07/410/027-052 |
Binocrit |
Lihtenšteina |
30.4.2011. |
|
EU/1/07/411/027-052 |
Epoetin alfa Hexal |
Lihtenšteina |
30.4.2011. |
|
EU/1/07/420/002 |
Cyanokit |
Islande |
20.1.2011. |
|
EU/1/07/420/002 |
Cyanokit |
Norvēģija |
14.2.2011. |
|
EU/1/07/422/005-006 |
Tasigna |
Islande |
23.3.2011. |
|
EU/1/07/422/005-006 |
Tasigna |
Norvēģija |
21.1.2011. |
|
EU/1/07/422/005-006 |
Tasigna |
Lihtenšteina |
28.2.2011. |
|
EU/1/07/438/005-006 |
Myfenax |
Lihtenšteina |
30.6.2011. |
|
EU/1/07/439/005-006 |
Mycophenole mofetil Teva |
Lihtenšteina |
30.6.2011. |
|
EU/1/08/461/002 |
Firazyr |
Lihtenšteina |
30.4.2011. |
|
EU/1/08/490/017-024 |
Pramipexole Teva |
Lihtenšteina |
30.6.2011. |
|
EU/1/09/511/005 |
Conbriza |
Lihtenšteina |
30.4.2011. |
|
EU/1/09/535/015-016 |
Grepid |
Lihtenšteina |
28.2.2011. |
|
EU/1/09/545/011-015 |
Onglyza |
Islande |
14.4.2011. |
|
EU/1/09/545/011-015 |
Onglyza |
Norvēģija |
25.3.2011. |
|
EU/1/09/545/011-015 |
Onglyza |
Lihtenšteina |
30.4.2011. |
|
EU/1/09/581/003-008 |
Resolor |
Lihtenšteina |
28.2.2011. |
|
EU/1/10/614/002 |
Menveo |
Lihtenšteina |
30.4.2011. |
|
EU/1/96/022/035-040 |
Zyprexa |
Lihtenšteina |
28.2.2011. |
|
EU/1/97/033/005-006 |
Avonex |
Lihtenšteina |
30.6.2011. |
|
EU/1/99/103/005 |
ReFacto AF |
Islande |
6.6.2011. |
|
EU/1/99/103/005-008 |
ReFacto AF |
Norvēģija |
1.6.2011. |
|
EU/1/99/103/005-008 |
ReFacto AF |
Lihtenšteina |
30.6.2011. |
|
EU/2/07/078/009-010 |
Rheumocam |
Islande |
18.4.2011. |
|
EU/2/07/078/009-010 |
Rheumocam |
Norvēģija |
9.2.2011. |
|
EU/2/07/078/009-010 |
Rheumocam |
Lihtenšteina |
28.2.2011. |
|
EU/2/07/078/011-014 |
Rheumocam |
Islande |
28.6.2011. |
|
EU/2/07/078/011-014 |
Rheumocam |
Lihtenšteina |
30.6.2011. |
|
EU/2/08/082/007 |
Zactran |
Lihtenšteina |
30.6.2011. |
|
EU/2/97/004/041-048 |
Metacam |
Lihtenšteina |
28.2.2011. |
|
EU/2/98/010/025 |
Econor |
Islande |
18.2.2011. |
|
EU/2/98/010/025 |
Econor |
Lihtenšteina |
28.2.2011. |
|
EU/99/119/017-018 |
NovoRapid |
Lihtenšteina |
30.4.2011. |
IV PIELIKUMS
Atsauktu tirdzniecības atļauju saraksts
Šādas tirdzniecības atļaujas atsauktas EEZ EBTA valstīs laika posmā no 2011. gada 1. janvāra līdz 30. jūnijam:
|
ES numurs |
Ražojums |
Valsts |
Atsaukšanas datums |
|
EU/1/03/259/001-006 |
Onsenal |
Islande |
20.4.2011. |
|
EU/1/03/259/001-006 |
Onsenal |
Lihtenšteina |
30.4.2011. |
|
EU/1/05/326/001 |
Ionsys |
Islande |
20.4.2011. |
|
EU/1/06/353/001-005 |
Thelin |
Islande |
15.3.2011. |
|
EU/1/06/353/001-005 |
Thelin |
Lihtenšteina |
28.2.2011. |
|
EU/1/08/449/001-008 |
Filgrastim ratiopharm |
Lihtenšteina |
30.4.2011. |
|
EU/1/08/449/001-008 |
Filgrastim ratiopharm |
Islande |
12.5.2011. |
|
EU/1/09/542/001-007 |
Clopidogrel 1A Pharma |
Lihtenšteina |
28.2.2011. |
|
EU/1/09/542/001-007 |
Clopidogrel 1A Pharma |
Islande |
16.3.2011. |
|
EU/1/09/547/001-007 |
Clopidogrel Sandoz |
Lihtenšteina |
30.4.2011. |
|
EU/1/10/629/001 |
Humenza |
Islande |
29.6.2011. |
|
EU/1/10/629/001 |
Humenza |
Lihtenšteina |
30.6.2011. |
V PIELIKUMS
Apturētu tirdzniecības atļauju saraksts
Šādas tirdzniecības atļaujas apturētas EEZ EBTA valstīs laika posmā no 2011. gada 1. janvāra līdz 30. jūnijam:
|
ES numurs |
Ražojums |
Valsts |
Apturēšanas datums |
|
EU/1/00/137/002-018 |
Avandia |
Islande |
13.1.2011. |
|
EU/1/03/258/001-022 |
Avandamet |
Islande |
13.1.2011. |
|
EU/1/06/349/001-010 |
Avaglim |
Islande |
17.1.2011. |
|
EU/2/06/058/001-003 |
Flexicam |
Islande |
14.1.2011. |
|
EU/2/08/088/001-003 |
Acticam |
Norvēģija |
7.3.2011. |
|
EU/2/09/099/001-006 |
Suvaxyn PCV |
Islande |
22.3.2011. |